CDKN1B and lung carcinoma: Interestingly, miR-196a-5p is highly expressed in gastric cancer cells and targets the cell cycle inhibitor CDKN1B (p27kip1), leading to increased cell proliferation [104], while miR-153-3p acts on AKT3 in lung cancer reducing cell proliferation rate [105].